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ABSTRACT 
In this paper, we describe a model for representing scientific 
knowledge of risk factors in medicine in an explicit format 
which enables its use for automated reasoning. The resulting 
model supports linking the conclusions of up-to-date clinical 
research with data relating to individual patients. This model, 
which we have implemented as an ontology-based system using 
Linked Data, enables the capture of risk factor knowledge and 
serves as a translational research tool to apply that knowledge to 
assist with patient treatment, lifestyle, and education. 
Knowledge captured using this model can be disseminated for 
other intelligent systems to use for a variety of purposes, for 
example, to explore the state of the available medical 
knowledge. 
Categories and Subject Descriptors 
H.2.8 Database applications – scientific databases 
I.2.1 Applications and Expert Systems – Medicine and Science 
I.2.4 Knowledge Representation Formalisms and methods 
General Terms 
Measurement, Design, Experimentation, Standardization. 
Keywords 
Health, comorbidities, risk, scientific modelling, knowledge 
capture, semantics, ontology, Linked Data. 
1. INTRODUCTION 
An important task in medicine is the assessment of risk. This 
depends on scientific knowledge derived by rigorous clinical 
studies regarding the (quantified) factors affecting clinical 
changes. Existing risk prediction tools typically only cover a 
very limited range of patient states, and the scientific knowledge 
informing the predictions is hardcoded into the tool. This makes 
them limited in application, particularly for patients with 
comorbidities (multiple co-occurring conditions), and rapidly 
out of date. An explicit representation of this knowledge, 
covering a wide (and, more importantly, expandable) range of 
risks and outcomes, would enable more sophisticated and 
maintainable risk prediction, prevention and management. 
We present here a model for representing the scientific 
knowledge of risk factors in just such a way. Existing work on 
modelling risks in clinical research focuses on the process and 
detail of clinical studies performed to identify and quantify risk 
factors. The work presented here focuses instead on the output 
of such clinical studies and proposes a generic model for the 
concept of health risk factor.  
Representations of scientific knowledge regarding health risk 
factors will be useful in clinical decision support systems and 
personalised care services. Additionally, intelligent systems can 
analyse knowledge regarding a particular medical subdomain in 
order to identify gaps or interesting areas in currently available 
research. This work was carried out in the context of the EU 
funded FP7-ICT project CARRE (Grant no. 611140), which 
seeks to provide personalised decision support to patients in 
managing comorbidities associated with cardiorenal disease.  
2. PREVIOUS WORK 
A number of models have been proposed for capturing various 
aspects of clinical research at various levels of granularity. As 
there is no other model addressing the concept of risk factor, to 
the best of our knowledge, we compare related work addressing 
similar concepts and level of abstraction. In particular, we 
consider the Ontology-Based eXtensible data model (OBX, [1]), 
the models maintained by the Clinical Data Interchange 
Standards Consortium (CDISC, [2]), and the Ontology of 
Clinical Research (OCRe, [3]). 
OBX was designed for the Immunology Database and Analysis 
Project (Immport, [4]) to be a generic model for representing the 
results of clinical research, including data from case report 
forms down to molecular data from specimens. It represents 
significant details of experimental design, modelling them at a 
high enough level to make it possible to capture many different 
kinds of research output. The aim of OBX is to promote data 
reuse. However, it does not focus on the broader scientific 
knowledge which can be learned from this data after suitable 
statistical analysis. A “Finding” in OBX is designed to represent 
the outcome of a particular assay or test, such as a blood sample 
analysis or a patient assessment, not a population-level risk 
factor. 
The CDISC standards, and OCRe, both take a more top-down 
approach to the modelling of clinical research, although from 
different perspectives. CDISC are responsible for standards 
relating to the data required for case report forms and the 
requirements and concepts in clinical trial structures necessary 
for regulatory reporting to the US Federal Drug Administration 
(FDA). In general, these models are focused on data interchange 
formats and on the conceptual modelling of proposed and 
ongoing clinical trials, in order to support the vital but complex 
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reporting needed for regulatory purposes. OCRe is also a formal 
model of the clinical trials process, but from a much more 
scientific perspective than the CDISC standards. OCRe models 
the design and analysis of a clinical research study in great detail 
and accommodates the wide range of possible types of study. 
The aim is to represent the scientific knowledge about studies in 
order to promote reuse, accountability and transparency in the 
scientific process in medicine. For example, OCRe is used by 
the Human Studies Database Project (HSDB, [5]) to support 
federated querying of data regarding human studies across a 
range of institutions holding such data. One of the use cases of 
OCRe is to support search and aggregation of trial data in order 
at least to semi-automate literature research to conduct 
systematic reviews and meta-analysis. 
A general theme of all of these models is the focus on the 
knowledge about the science, to promote different kinds of good 
working practice in research and to support research-related 
tasks. That is, existing models aim to support the process of 
generating new scientific knowledge in medicine (i.e. new 
medical evidence). What we do not see are models intended to 
support the application of scientific results in practice. 
Treatment guidelines or lifestyle recommendations for patients 
typically come from the output of the systematic review process, 
and constitute the vast amount of medical evidence on which 
clinical practice is largely based. The model presented here is 
intended to remedy that omission. This work is thus 
complementary to the existing modelling work, and it would be 
fruitful to work further on the possible ways to link these 
models, to promote the full “bench-to-bedside” pathway.  
Existing algorithms for risk prediction for, e.g., cardiovascular 
risk, include the Framingham equation [6], the Joint British 
Societies (JBS) formula [7] and the ASSIGN score [8]. These 
only take account of a limited set of risk factors and possible 
outcomes, as these have been produced by specific clinical 
studies – thus can be limited in application. For example, the 
ASSIGN score is specialised for Scottish populations, and, while 
Framingham includes diabetes as a risk factor, it is omitted from 
the JBS formula (diabetic patients are always high-risk). More 
fundamentally, each of these hardcode the scientific knowledge 
about risk into the prediction formula itself, thus requiring new 
versions to be created to accommodate new scientific 
knowledge. By concentrating on the explicit modelling of this 
knowledge, it is possible to separate the knowledge from the 
reasoning task to be carried out with it, allowing new and 
updated knowledge to be added easily and in a transparent 
fashion.  
3. RISK FACTORS 
The following subsections present the requirements for 
modelling the concept of risk factor in medicine, how this is 
quantified and estimated via evidence from research studies.  
3.1 Risk factors in medicine 
In medicine, risk is the probability of a negative outcome on the 
health of a population of subjects. The agents responsible for 
that risk are called risk factors when they aggravate a situation 
and are used to predict (up to a degree) the occurrence of a 
condition or deterioration of a patient’s health dividing the 
population into high and low risk groups [9]. In general, risk 
factors can be:  
− Environmental: Chemical, physical, mechanical, 
biological and psychosocial elements that constitute risk 
factors to public health.   
− Demographic: Empirical findings have pointed out that 
age, sex, race, location, and religion all affect public health.  
− Genetic: Any predisposition to conditions and habits 
hardcoded in the human genome. 
− Behavioral/Lifestyle-related Human behaviors that are 
marked as “risky” and have proven to cause deterioration 
or provide added risk, such as smoking, overeating, 
unprotected sex, excessive alcohol consumption, drug 
abuse and a sedentary lifestyle.   
− Biomedical: These include clinical diagnoses such as 
diabetes, and states such as pregnancy, present in a patient 
that can influence his/her health by creating or affecting 
other conditions. 
Each of the above elements, severally or in combination, may be 
descriptive of a particular patient or population, and may 
predispose such a patient/member of that population to develop 
further such conditions.  
Extending work on general risk analysis [10],[11], we can 
present a risk factor as a triplet, which includes the source of the 
risk, the outcome and an expression of their association. The 
source of the risk is an agent (an event, a condition, a disorder or 
any other factor) that is shown via empirical studies to be 
associated with a consequence, that is, the outcome. The 
outcome itself is a negative health condition or disorder. Most 
often the outcome itself is found to be a source of another risk 
factor.  
Thus in the general case the source and the outcome can both be 
treated as health related conditions (including disorders). In this 
work, we collectively refer to both the source and the outcome 
as risk elements. Not all elements can occur in both roles. In 
particular, “fixed markers” such as date of birth, genetics or 
ethnic origin cannot be modified or affected by anything, and so 
cannot be the outcome of a risk [12]. 
The association between the source and the outcome is a 
complex construct which describes the type of relation, the 
likelihood of an outcome to occur, and the initial conditions 
under which such likelihood can be estimated. The relation 
between the source and the outcome may not always be proven 
causation. Following the Unified Medical Modelling System’s 
(UMLS) Semantic Network [13], associations between a risk 
factor and the associated condition may include:   
− issue_in: the risk factor is a point of discussion for a 
condition;  
− affects: the risk factor produces a direct effect on the 
condition; 
− causes: the risk factor brings about the condition; and   
− complicates: the risk factor causes another (risk) factor to 
become more complex (recursive).   
3.2 Risk probability 
The existence of a risk factor is not a determinant of 
consequence but the degree of its influence can be statistically 
calculated. The way to measure the likelihood requires a certain 
quantitative biomarker and observational studies that statistically 
calculate a probability. Different study designs and analyses can 
generate different types of probability measures [14].  
A commonly used risk measure is the Relative Risk or Risk ratio 
(RR), which is the ratio of the probability of an event occurring 
(for example, developing a disease) in an exposed group to the 
probability of the event occurring in a non-exposed group.  
Another metric of relative risk is the Hazard Ratio (HR) (e.g. 
[15]) which is most often used in clinical studies to assess the 
instantaneous risk at any time of a given study. So, it accounts 
for the reality that some subjects may drop out of the study 
before the event of interest happens, or that the study may end 
before all of the subjects experience the event (time-to-event 
analysis).  
Note that these representations of probability are the standard 
forms found in medical literature. In the interests of accuracy 
and relevancy to the intended clinical audience, we follow the 
medical conventions.  
Empirically determined probabilities across populations can 
come with a range of associated qualifiers. A probability 
determined from a clinical study lies within a confidence 
interval, and the study design/analysis may have been adjusted, 
or not, for certain factors (for example, age, sex, and so on). In 
order to be able to properly represent risk factors, these must be 
included – especially where the goal is to produce personalised 
risk calculations.  
3.3 Observables 
An event, a condition, a disorder or any other factor becomes a 
risk source when certain conditions are met. These conditions 
are associated with one or more observable, which is either 
environmental or a physical or mental property of the patient.  
So, for example, medical evidence suggests that obesity is a risk 
factor for diabetes [16]. However, if we want to be able to report 
a certain probability measure, we have to define what obesity 
means for the sample population used to calculate the statistics. 
Common observables to quantify obesity include waist 
circumference, waist to hip ratio, waist to height ratio, body fat 
percentage and body mass index (BMI, i.e. body mass divided 
by height squared). In the particular systematic review and meta-
analysis mentioned here, people with waist circumference 
between 79.3 and 107.5 have a risk ratio of 1.65 to develop 
diabetes (as compared to people with lower values for waist 
circumference).  
Therefore, in order to describe properly a risk association we 
have to state a specific observable that provides a 
measure/description of the risk source and the specific condition 
or value of this observable. For the same risk factor, a number of 
different risk associations can be measured in the literature, each 
association corresponding to a different observable or a different 
observable condition or even different combinations of 
observables corresponding to different concurrent risk sources.   
In another example, medical evidence suggests that obesity is a 
risk factor for coronary arterial disease [17]. In this particular 
systematic review and meta-analysis, men with a BMI between 
25 and 30 kg/m2 were found to have a risk ratio of 1.29 to 
develop coronary arterial disease (as compared to normal male 
of a BMI 18.5 to 25 kg/m2). A different risk association (for the 
same risk) is found for men of a BMI greater than 30 kg/m2, 
who present an elevated risk ratio of 1.72. The same evidence 
source shows that women with a BMI between 25 and 30 kg/m2 
have a risk ratio of 1.80 to develop coronary arterial disease and 
when their BMI is above 30 kg/m2 the risk ratio is elevated to 
3.10. Thus in this example, four different associations are 
described between the risk source of obesity (and age) and the 
outcome of coronary arterial disease.  
3.4 Medical evidence provenance & quality  
Risk factors are derived from population statistical studies. The 
cornerstone of evidence based medicine is that such studies are 
the only source of knowledge regarding clinical risk, and thus, 
for two reasons, it is important that evidence be represented 
explicitly in our model. The first is provenance: no one could (or 
should) trust data purporting to represent clinical knowledge 
without the ability to trace it back to its source. The second is 
the question of quality. Sources of evidence can range from 
small in vitro studies or case reports to large randomized clinical 
trials, to meta-analyses of systematic reviews. All these 
population studies carry a different level of evidence. In the past, 
various evidence ranking schemes have been used, to appraise 
quality of evidence, based on study design and methodology 
utilized; one such commonly used scheme is the grading system 
proposed by The Oxford Centre for Evidence-Based Medicine 
[18]. 
4. A MODEL OF RISK  
4.1 Risk factor model 
The term risk factor is used in the medical literature seemingly 
interchangeably to indicate a risk source and/or the particular 
association. For clarity in the proposed model, we use the term 
risk element to indicate the risk source and/or the outcome (as 
described above), and the term risk association to refer to a 
specific triple of “source-association-target” when coupled to a 
particular observable condition, its probability, and evidence 
source. Based on this description, primary concepts and their 
relationships are identified in the paragraphs below and shown 
schematically in Figure 1.  
Risk Element: A risk association defines the (often causal) 
association of an agent (source risk element) to a health outcome 
(target risk element). This outcome is in most cases negative, 
and most often the (causal) agent is in itself a negative health 
outcome. In this sense, risk agents and their outcomes can be 
seen as instances of the same entity, called here ‘risk element’. 
Risk elements include all the disorders/diseases, as well as any 
other risk causing agent as discussed in Section 3.1, e.g. 
demographic, genetic, behavioural, environmental, or even 
interventions (e.g. pharmaceutical substances, contrast agents). 
Risk Association: The association of one risk element as the 
risk source with another risk element which is the negative 
outcome under certain conditions is a ‘risk association’. Note 
that a source risk element can be associated to a target risk 
element with more than one risk association. This association is 
a rather complex one and is characterized by a number of other 
concepts: 
− Association Type: The association can be of a certain 
‘association type’; most often, it is of type ‘causes’, but it 
can also be ‘complicates’, otherwise ‘affects’ or in the 
general case (and when there is no knowledge of a specific 
effect), ‘is an issue in’. There are also cases where an agent 
can have a positive effect, that is “reduces” the risk of a 
negative outcome. Generally, a number of other semantic 
relationships as described in UMLS could be encountered 
here.  
− Risk Ratio: The association is always accompanied by the 
likelihood of the negative outcome to occur. This 
likelihood is expressed as a ‘risk ratio’, that is the ratio of 
the probability of the negative outcome when the person is 
exposed to the risk agent over the probability of the 
negative outcome when the person is not exposed to the 
risk agent. The risk ratio has a certain type (e.g. relative 
risk ratio, hazard ratio, etc.); a value (a positive real 
number, which when below 1 indicates a reduced risk 
compare to the control population and when greater than 1 
indicates an elevated risk); a confidence interval; and a list 
of population characteristics for which the study was 
adjusted.  
− Observables Condition: For the association to occur, certain 
circumstances should exist. These prerequisite 
circumstances relate directly to the existence of the risk 
agent (source risk target) and/or its severity, and/or any 
other specific conditions. These are reported via certain 
‘observables’, that is, variables that can be measured or 
otherwise ascertained (e.g. biomarkers, biometric variables, 
biological signals and other non-biological factors e.g. 
environmental). The circumstances thus are ascertained via 
an explicit logical expression that involves observables; 
this logical expression is termed ‘observables condition’.  
− Evidence Source: Risk associations in medicine are 
determined from clinical studies as reported in evidence 
based medical literature. Thus each association is directly 
related to an ‘evidence source’ which is a specific scientific 
publication.  
4.2 Standardized concept descriptions 
To ensure that the model can be seamlessly integrated into 
existing medical information systems, we adopt the commonly 
used standards and controlled vocabularies in the description of 
the concepts presented above. For example, risk elements of 
type biomedical include an ICD-10 [19] classifier, of type 
demographic, a SNOMED-CT [20] classifier. Other controlled 
vocabularies used for risk elements of type environmental or 
intervention include SNOMED-CT, RxNorm [21], and EnvO 
[22]. Measurements and units follow the QUDT [23] and UO 
[24] ontologies. Evidence sources are described using their DOI 
and/or their PubMed identifier, while evidence level follows the 
OCEBM system [18]. In general, where available UMLS [25] 
codes are also used.  
5. IMPLEMENTATION & EVALUATION 
This model was used to capture scientific information on 
medical risk factors in the area of cardiorenal disease. Chronic 
cardiorenal disease is the condition characterized by 
simultaneous kidney and heart disease while the primarily 
failing organ may be either the heart or the kidney. Very often 
the dysfunction occurs when the failing organ precipitates the 
failure of the other. The cardio-renal patient (or the person at 
risk of this condition) presents an interesting case example for 
exploring risk factors, as (a) is a complex comorbid condition 
which involves and is affected by a number of related health 
disorders as well as lifestyle related factors; (b) chronic 
cardiorenal disease has an increasing incidence and a number of 
serious (and of increasing incidence) comorbidities, including 
diabetes and hypertension, and may lead to serious chronic 
conditions such as nephrogenic anemia, renal osteodystrophy, 
peripheral neuropathy, malnutrition, and various systemic 
diseases (e.g. rheumatoid arthritis, lupus erythematosus); and (c) 
prevention is of major importance. Good appreciation of risks 
therefore plays an important role for the various stages of 
cardiorenal disease evolution, from normal health condition, to 
chronic disease, to end-stage renal deficiency and/or heart 
failure.  
To test and put the model into use, a group of 8 medical doctors 
(members of the CARRE project team) reviewed current 
medical literature to identify major risk factors related to 
cardiorenal syndrome. At this time, 98 different risk factors 
were identified and described formally using the proposed 
model. The descriptions resulted in 268 respective associations. 
There were 45 involved risk elements, corresponding to a total 
of 47 different observables. The evidence sources used were 62 
scientific publications. The review methodology and the 
available descriptions in text (tabular) format are provided in 
CARRE Deliverable 2.2. available from the project site [26]. 
This process of testing and using the proposed model resulted in 
the following qualitative findings. The medical experts found 
the model straightforward to use to describe risk factors. The 
terminology used was found to be familiar and thus easy to 
understand and apply to describe risk factors found in the 
literature and also to read descriptions already produced by 
 
Figure 1 Basic concepts and their relationships 
 
 
Figure 2 A visual overview of currently encoded risk factors, with some examples highlighted.
colleagues. The only difficulty identified related to expressing 
accurately and rigorously the observables’ condition that has to 
be satisfied in order for a risk association to hold. Initially, 
medical experts were asked to produce this condition in the 
conventional way this is written in the literature, using natural 
language – which was a straightforward task. Subsequently, they 
were asked to reformat this condition using a logical operator 
expression (so that this expression can be easily translated to 
computer readable format). This task proved to be more 
cumbersome and required 1-2 hours training and testing before 
the medical experts could independently produce correct 
expressions.  
In order to enable the open and seamless use and reuse of these 
described medical risk factors, we have developed an on-line 
web based system for their description. Also,  the resulting risk 
factor descriptions are available as Linked Data [27], in the 
Resource Description Framework (RDF) format [28], via an 
open access RDF repository. 
The web-based system was developed by customizing the 
Drupal content management system Error! Reference source 
not found. to reflect the structure of the model presented here, 
so that observables, evidence sources, risk elements and 
associations can be entered via web forms, and automatically 
translated to RDF. The system maintains referential integrity, so 
that if, for example, “diabetes” is entered as a risk element 
entity, then a risk association representing an observed link 
between diabetes and hypertension will refer to the existing 
diabetes risk element entity. Users are supported in the reuse of 
data already entered into the system by the user interface, which 
allows existing relevant entities to be selected via drop-down 
lists wherever possible. Customisation is straightforward: 
Drupal allows the definition of custom content types (e.g., risk 
factor) annotated with RDF terms, so that when data for a 
particular risk factor is entered, it can be made automatically 
available as RDF. 
Figure 2 illustrates a projection of the various risk factors, as 
captured by the medical experts in the context of our project. 
The diagram contains 93 distinct risk factor associations. These 
associations are constructed combining 45 different risk 
elements, used either as source or target (or both). Highlighted 
in Figure 2 is the example of age and ischemic heart disease 
increasing a patient’s risk of a stroke. It can also be seen how 
many risk elements increase the risk of heart failure, and how 
many elements are at an increased risk in obese patients. 
6. DISCUSSION 
The model presented in this paper enables the clinical experts to 
encode the risk associations between biological, demographic, 
lifestyle and environmental elements and clinical outcomes in 
accordance with evidence from the clinical literature. While the 
motivation and initial thinking regarding the model was focused 
on factors which increase the probability of negative 
consequences, the end result is equally as capable of modelling 
factors which decrease those probabilities, or which affect the 
probability of positive consequences. In other words, it is just as 
straightforward to represent, for example, an intervention with 
the potential to lower a patient’s body mass index. 
The encoded data is useful for reasoning about personalised 
medical risk, both actual and hypothetical. In particular, 
reasoning related to actual or potential comorbidities is 
supported by the model. By implementing the model using 
standard semantic technologies, it is possible to link both model 
and data to other clinical models (such as OCRe and OBX trial 
and data descriptions) and to external sources of data (e.g., 
environmental risk factors could be linked to open sources of 
environmental data). 
Nothing in the model is specific to the motivating domain of 
cardiorenal conditions, and extension to risk factors relating to 
other domains of medicine is not anticipated to pose any 
problems. Extending to more ‘distant’ domains where evidence-
based risk calculation is relevant (e.g., climate science) ought 
also to be practical. The model already accommodates different 
representations of probability, and so could be adapted to those 
representations suitable to the new domain’s conventions, and 
the concept of “observable” is already generic. It would be 
necessary to extend the notion of evidence, and in particular, 
evidence quality, which is currently dependent on medical 
definitions. 
The benefit of modelling risks explicitly in this way is that it 
gives a very easy to follow overview of the field of medicine 
under consideration, showing at a glance both which risks are 
increased by multiple factors, which factors lead to multiple 
risks, as well as which associations have received more (or less) 
research attention. Compared to existing risk prediction models, 
this approach has a significant advantage in being able to be 
expanded and updated easily as clinical knowledge increases 
and changes. 
It should be noted that the model is intended to capture medical 
evidence as presented in current medical literature. The 
predictive accuracy of the model is thus directly linked to and 
depended on this knowledge. Figure 2 projects only the risk 
association relationship, excluding the other details and 
relationships encoded in the model. The full range of knowledge 
captured in the model supports a sophisticated analysis of the 
kind which is difficult and time-consuming to undertake 
manually. We intend to pursue such analysis in future work.  
The difficulty with clinical scientific knowledge is the necessity 
to keep it accurate and up to date, and we are currently exploring 
the best process for curating a knowledge base of risk factors. 
However, the encoding task proved to be quite straightforward 
for our medical experts. 
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